Fig. 1From: Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritisa–c Predicted probability (with 95% confidence limits) of patients with radiographic progression (yes/no) based on a SJC28, b PhGA, and c CRP. CRP, C-reactive protein; PhGA, physician global assessment; SJC28, 28 swollen joint countBack to article page